These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10026168)

  • 1. Structural features of the ligand-binding domain of the serotonin 5HT3 receptor.
    Yan D; Schulte MK; Bloom KE; White MM
    J Biol Chem; 1999 Feb; 274(9):5537-41. PubMed ID: 10026168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of D-tubocurarine analogs with the 5HT3 receptor.
    Yan D; Pedersen SE; White MM
    Neuropharmacology; 1998; 37(2):251-7. PubMed ID: 9680250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topology of ligand binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Brain Res Brain Res Rev; 1997 Oct; 25(2):133-91. PubMed ID: 9403137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the ligand binding site of the 5-HT3 receptor using site directed mutagenesis: importance of glutamate 106.
    Boess FG; Steward LJ; Steele JA; Liu D; Reid J; Glencorse TA; Martin IL
    Neuropharmacology; 1997; 36(4-5):637-47. PubMed ID: 9225289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the ligand-binding site of the serotonin 5-HT3 receptor: the role of glutamate residues 97, 224, AND 235.
    Schreiter C; Hovius R; Costioli M; Pick H; Kellenberger S; Schild L; Vogel H
    J Biol Chem; 2003 Jun; 278(25):22709-16. PubMed ID: 12660235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of tryptophan residues in the 5-Hydroxytryptamine(3) receptor ligand binding domain.
    Spier AD; Lummis SC
    J Biol Chem; 2000 Feb; 275(8):5620-5. PubMed ID: 10681544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors.
    Arias HR
    Neurochem Int; 2000 Jun; 36(7):595-645. PubMed ID: 10771117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cation-pi interactions in ligand recognition by serotonergic (5-HT3A) and nicotinic acetylcholine receptors: the anomalous binding properties of nicotine.
    Beene DL; Brandt GS; Zhong W; Zacharias NM; Lester HA; Dougherty DA
    Biochemistry; 2002 Aug; 41(32):10262-9. PubMed ID: 12162741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of critical residues in loop E in the 5-HT3ASR binding site.
    Venkataraman P; Venkatachalan SP; Joshi PR; Muthalagi M; Schulte MK
    BMC Biochem; 2002 Jun; 3():15. PubMed ID: 12079500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of d-tubocurarine binding site of Torpedo acetylcholine receptor.
    O'Leary ME; Filatov GN; White MM
    Am J Physiol; 1994 Mar; 266(3 Pt 1):C648-53. PubMed ID: 8166227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of d-tubocurarine analogs with mutant 5-HT(3) receptors.
    Yan D; White MM
    Neuropharmacology; 2002 Sep; 43(3):367-73. PubMed ID: 12243766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
    Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different efficacy of specific agonists at 5-HT3 receptor splice variants: the role of the extra six amino acid segment.
    Niemeyer MI; Lummis SC
    Br J Pharmacol; 1998 Feb; 123(4):661-6. PubMed ID: 9517385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locating an antagonist in the 5-HT3 receptor binding site using modeling and radioligand binding.
    Thompson AJ; Price KL; Reeves DC; Chan SL; Chau PL; Lummis SC
    J Biol Chem; 2005 May; 280(21):20476-82. PubMed ID: 15781467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling.
    Mialet J; Dahmoune Y; Lezoualc'h F; Berque-Bestel I; Eftekhari P; Hoebeke J; Sicsic S; Langlois M; Fischmeister R
    Br J Pharmacol; 2000 Jun; 130(3):527-38. PubMed ID: 10821780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of tryptamine and ergoline compounds with threonine 196 in the ligand binding site of the 5-hydroxytryptamine6 receptor.
    Boess FG; Monsma FJ; Meyer V; Zwingelstein C; Sleight AJ
    Mol Pharmacol; 1997 Sep; 52(3):515-23. PubMed ID: 9284367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of Torpedo nicotinic acetylcholine receptor gamma Trp-55 and delta Trp-57 to agonist and competitive antagonist function.
    Xie Y; Cohen JB
    J Biol Chem; 2001 Jan; 276(4):2417-26. PubMed ID: 11056174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicted structure of the extracellular region of ligand-gated ion-channel receptors shows SH2-like and SH3-like domains forming the ligand-binding site.
    Gready JE; Ranganathan S; Schofield PR; Matsuo Y; Nishikawa K
    Protein Sci; 1997 May; 6(5):983-98. PubMed ID: 9144769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of residues in transmembrane regions III and VI that contribute to the ligand binding site of the serotonin 5-HT6 receptor.
    Boess FG; Monsma FJ; Sleight AJ
    J Neurochem; 1998 Nov; 71(5):2169-77. PubMed ID: 9798944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward atomic-scale understanding of ligand recognition in the muscle nicotinic receptor.
    Sine SM; Wang HL; Gao F
    Curr Med Chem; 2004 Mar; 11(5):559-67. PubMed ID: 15032604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.